Back to Treatments

Treatment

Bortezomib

1
Conditions
591
Trials
25K
Participants
50%
Average Safety

Condition Evidence

Multiple myeloma

591 trials · 25K participants

88% effectiveness · 50% safety
Bortezomib | DFDA